Virus-Related Carcinoma — Trials

Virus-Related Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

169 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 74
Recruiting: 38
Ph III recruiting: 2
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07578467	Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs	not yet recruiting	Phase 1 / Phase 2	35	Abramson Cancer Center at Penn MedicineOTHER	0	Jul 8, 2026	clinicaltrials
NCT06505551	Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma	not yet recruiting	Phase 1 / Phase 2	66	SCG Cell Therapy Pte. Ltd.INDUSTRY	0	Jul 17, 2024	clinicaltrials